vs

Side-by-side financial comparison of MESOBLAST LTD (MESO) and OLB GROUP, INC. (OLB). Click either name above to swap in a different company.

MESOBLAST LTD is the larger business by last-quarter revenue ($1.9M vs $1.8M, roughly 1.1× OLB GROUP, INC.). OLB GROUP, INC. runs the higher net margin — -83.7% vs -959.3%, a 875.6% gap on every dollar of revenue. On growth, MESOBLAST LTD posted the faster year-over-year revenue change (-3.6% vs -35.2%).

Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004.

OLB Group, Inc. is a global financial technology provider offering omnichannel payment processing solutions, e-commerce enablement tools, and digital banking services for small and medium-sized enterprises across North America, Europe, and key Asia-Pacific markets. Its core segments include merchant services, crypto payment integration, and cloud-based business management platforms.

MESO vs OLB — Head-to-Head

Bigger by revenue
MESO
MESO
1.1× larger
MESO
$1.9M
$1.8M
OLB
Growing faster (revenue YoY)
MESO
MESO
+31.6% gap
MESO
-3.6%
-35.2%
OLB
Higher net margin
OLB
OLB
875.6% more per $
OLB
-83.7%
-959.3%
MESO

Income Statement — Q3 FY2023 vs Q4 FY2025

Metric
MESO
MESO
OLB
OLB
Revenue
$1.9M
$1.8M
Net Profit
$-18.6M
$-1.5M
Gross Margin
Operating Margin
-83.7%
Net Margin
-959.3%
-83.7%
Revenue YoY
-3.6%
-35.2%
Net Profit YoY
12.7%
67.5%
EPS (diluted)
$-0.03
$-0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MESO
MESO
OLB
OLB
Q4 25
$1.8M
Q3 25
$2.3M
Q2 25
$2.3M
Q1 25
$2.3M
Q4 24
$2.7M
Q3 24
$3.1M
Q2 24
$3.5M
Q1 24
$3.5M
Net Profit
MESO
MESO
OLB
OLB
Q4 25
$-1.5M
Q3 25
$-1.2M
Q2 25
$-2.1M
Q1 25
$-1.1M
Q4 24
$-4.6M
Q3 24
$-1.6M
Q2 24
$-2.6M
Q1 24
$-2.4M
Operating Margin
MESO
MESO
OLB
OLB
Q4 25
-83.7%
Q3 25
-49.1%
Q2 25
-74.8%
Q1 25
-36.6%
Q4 24
-166.0%
Q3 24
-52.9%
Q2 24
-74.3%
Q1 24
-82.6%
Net Margin
MESO
MESO
OLB
OLB
Q4 25
-83.7%
Q3 25
-50.8%
Q2 25
-93.7%
Q1 25
-46.9%
Q4 24
-167.1%
Q3 24
-52.9%
Q2 24
-75.2%
Q1 24
-67.8%
EPS (diluted)
MESO
MESO
OLB
OLB
Q4 25
$-0.48
Q3 25
$-0.13
Q2 25
$-0.66
Q1 25
$-0.47
Q4 24
$-3.55
Q3 24
$-0.92
Q2 24
$-1.49
Q1 24
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MESO
MESO
OLB
OLB
Cash + ST InvestmentsLiquidity on hand
$48.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$482.2M
$4.6M
Total Assets
$650.4M
$12.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MESO
MESO
OLB
OLB
Q4 25
Q3 25
Q2 25
Q1 25
$29.3K
Q4 24
$27.4K
Q3 24
$41.3K
Q2 24
$53.3K
Q1 24
$3.3K
Stockholders' Equity
MESO
MESO
OLB
OLB
Q4 25
$4.6M
Q3 25
$5.3M
Q2 25
$6.4M
Q1 25
$2.3M
Q4 24
$3.2M
Q3 24
$6.7M
Q2 24
$8.3M
Q1 24
$11.0M
Total Assets
MESO
MESO
OLB
OLB
Q4 25
$12.3M
Q3 25
$12.2M
Q2 25
$12.4M
Q1 25
$12.5M
Q4 24
$12.7M
Q3 24
$15.9M
Q2 24
$16.6M
Q1 24
$18.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MESO
MESO
OLB
OLB
Operating Cash FlowLast quarter
$-16.3M
$-1.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MESO
MESO
OLB
OLB
Q4 25
$-1.3M
Q3 25
$-115.5K
Q2 25
$-1.0M
Q1 25
$-155.8K
Q4 24
$-2.6M
Q3 24
$-376.7K
Q2 24
$-785.5K
Q1 24
$-424.7K

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MESO
MESO

Segment breakdown not available.

OLB
OLB

Transaction And Processing Fees$1.7M94%
Other$99.2K6%

Related Comparisons